Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00945334

Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome — C-IBS  

Constipation-predominant Irritable Bowel Syndrome Clinical Trial

Official title:
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome

Clinical Trial Summary

In this study the investigators aim to compare the efficacy of neomycin to a combination of rifaximin and neomycin in the treatment of C-IBS subjects with methane on their breath test. This study will be conducted in collaboration with Dr. John DiBaise at the Mayo Clinic in Scottsdale, AZ and Dr. Satish Rao in Georgia Regents University in Augusta, GA.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00945334
Study type Interventional
Source Cedars-Sinai Medical Center
Contact
Status Completed
Phase N/A
Start date August 2009
Completion date June 2013
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00742872 - Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome Phase 3
Completed NCT05164861 - Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations N/A
Withdrawn NCT05321953 - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation N/A
Not yet recruiting NCT06319729 - A Chinese Herbal Medicine for IBS-C Phase 2
Completed NCT01085643 - Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) N/A
Completed NCT03150212 - Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype N/A
Recruiting NCT05757037 - Laser Acupuncture on Irritable Bowel Syndrome in Females N/A
Completed NCT05392439 - Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome N/A
Not yet recruiting NCT05921383 - Anorectal Manometry of Patients With Constipation Predominant IBS
Recruiting NCT05134584 - Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Phase 4
Terminated NCT03336034 - Assessment of Responsiveness to Treatment by Experience Sampling Method
Not yet recruiting NCT04666155 - MOWOOT Device Treatment for Adults With Chronic Constipation N/A
Not yet recruiting NCT05941650 - To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome N/A
Completed NCT00912301 - Cheno Effect on Transit in Health and IBS-C Phase 2
Terminated NCT00607971 - Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) Phase 3